Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 134 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, [...] PAOLA-1/ENGOT-ov25 investigators
Ann Oncol, S0923-7534(24)04907-X, 09 Nov 2024
Cited by: 0 articles | PMID: 39528049
Add to export list
Modulation of leg trajectory by transcranial magnetic stimulation during walking
Bourgeois H, Guay-Hottin R, Meftah E, Martinez M, Bonizzato M, Barthélemy D
bioRxiv, 23 Oct 2024
Cited by: 0 articles | PPR: PPR930058
Add to export list Preprint
Multidisciplinary analysis of cancer-related fatigue at the time of diagnosis: preliminary results of the BIOCARE FActory cohort.
Leclercq A, Chatrenet A, Bourgeois H, Cojocarasu O, Mathie C, Martin T, Rahmani A, Morel B
Support Care Cancer, 32(5):319, 30 Apr 2024
Cited by: 0 articles | PMID: 38689167
Add to export list
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, Vergote I, Parma G, Nøttrup TJ, Lebreton C, Fasching PA, Pisano C, Manso L, Bourgeois H, Runnebaum I, Zamagni C, Hardy-Bessard AC, Schnelzer A, [...] Ray-Coquard I
Int J Gynecol Cancer, 34(4):550-558, 01 Apr 2024
Cited by: 3 articles | PMID: 38129136 | PMCID: PMC10982633
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Freyer G, Martinez-Jañez N, Kukielka-Budny B, Ulanska M, Bourgeois H, Muñoz M, Morales S, Calero JB, Cortesi L, Pintér T, Palácová M, Cherciu N, Petru E, Ettl J, de Almeida C, Villanova G, Raymond R, Minh CTT, Rodrigues A, Cazzaniga ME
Breast, 74:103681, 09 Feb 2024
Cited by: 1 article | PMID: 38377732 | PMCID: PMC10891320
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Balmaña J, Fasching PA, Couch FJ, Delaloge S, Labidi-Galy I, O'Shaughnessy J, Park YH, Eisen AF, You B, Bourgeois H, Gonçalves A, Kemp Z, Swampillai A, Jankowski T, Sohn JH, Poddubskaya E, Mukhametshina G, Aksoy S, Timcheva CV, [...] LUCY investigators
Breast Cancer Res Treat, 204(2):237-248, 19 Dec 2023
Cited by: 4 articles | PMID: 38112922 | PMCID: PMC10948524
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.
Bidard FC, Kiavue N, Jacot W, Bachelot T, Dureau S, Bourgeois H, Goncalves A, Brain E, Ladoire S, Dalenc F, Gligorov J, Teixeira L, Emile G, Ferrero JM, Loirat D, Cabel L, Kadi A, Diéras V, Alix-Panabières C, Pierga JY
J Clin Oncol, 42(4):383-389, 06 Nov 2023
Cited by: 3 articles | PMID: 37931185
Add to export list
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, [...] Vaur D
Clin Cancer Res, 29(21):4419-4429, 01 Nov 2023
Cited by: 4 articles | PMID: 37756555 | PMCID: PMC10618649
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The place of the relative at the time of the announcement of cancer progression: BABEL - a mixed-methods study.
Ingrand I, Laurent E, Lecomte T, Cojocarasu O, Egreteau J, Aleba A, Hureaux J, Colombat P, Gyan E, Bourgeois H
Palliat Support Care, 1-10, 26 Jun 2023
Cited by: 0 articles | PMID: 37357920
Add to export list
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.
Le Du K, Septans AL, Maloisel F, Vanquaethem H, Schmitt A, Le Goff M, Clavert A, Zinger M, Bourgeois H, Dupuis O, Denis F, Bouchard S
J Med Internet Res, 25:e38619, 15 Feb 2023
Cited by: 2 articles | PMID: 36790852 | PMCID: PMC9978987
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
Dubu J, Boyas S, Roland V, Landry S, Septans AL, Balavoine M, Bourgeois H, Pointreau Y, Denis F, Letellier C, Le Dû K
JMIR Res Protoc, 11(11):e40969, 25 Nov 2022
Cited by: 0 articles | PMID: 36427234 | PMCID: PMC9736768
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, [...] DESTINY-Breast04 Trial Investigators
N Engl J Med, 387(1):9-20, 05 Jun 2022
Cited by: 729 articles | PMID: 35665782 | PMCID: PMC10561652
Add to export list Free full text in Europe PMC
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Joly F, Fabbro M, Berton D, Lequesne J, Anota A, Puszkiel A, Floquet A, Vegas H, Bourgeois H, Bengrine Lefevre L, You B, Pommeret F, Lortholary A, Spaeth D, Hardy-Bessard AC, Abdeddaim C, Kaminsky-Forrett MC, Tod M, Kurtz JE, [...] Brachet PE
Gynecol Oncol, 166(3):389-396, 26 Jul 2022
Cited by: 6 articles | PMID: 35902297
Add to export list
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.
Tripathy D, Tolaney SM, Seidman AD, Anders CK, Ibrahim N, Rugo HS, Twelves C, Diéras V, Müller V, Du Y, Currie SL, Hoch U, Tagliaferri M, Hannah AL, Cortés J, ATTAIN Investigators
JAMA Oncol, 8(7):1047-1052, 01 Jul 2022
Cited by: 5 articles | PMID: 35552364 | PMCID: PMC9100460
Add to export list Free full text in Europe PMC
Effects of postactivation potentiation on mechanical output and muscle architecture during electrically induced contractions in plantar flexors.
Bourgeois H, Duchateau J, Baudry S
J Appl Physiol (1985), 132(5):1213-1222, 31 Mar 2022
Cited by: 1 article | PMID: 35358400
Add to export list
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, [...] DESTINY-Breast03 Trial Investigators
N Engl J Med, 386(12):1143-1154, 01 Mar 2022
Cited by: 407 articles | PMID: 35320644
Add to export list
The place of the relative at the time of the announcement of cancer progression. BABEL, a mixed-method study
INGRAND I, LAURENT E, LECOMTE T, COJOCARASU O, EGRETEAU J, ALEBA A, HUREAUX J, COLOMBAT P, GYAN E, Bourgeois H
Research Square, 01 Feb 2022
Cited by: 0 articles | PPR: PPR448924
Add to export list Preprint v1
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, [...] KEYNOTE-522 Investigators
N Engl J Med, 386(6):556-567, 01 Feb 2022
Cited by: 363 articles | PMID: 35139274
Add to export list
Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol.
Chartogne M, Leclercq A, Beaune B, Boyas S, Forestier C, Martin T, Thomas-Ollivier V, Landry S, Bourgeois H, Cojocarasu O, Pialoux V, Zanna O, Messonnier LA, Rahmani A, Morel B
BMC Cancer, 21(1):1140, 23 Oct 2021
Cited by: 3 articles | PMID: 34688272 | PMCID: PMC8542307
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
Fujiwara K, Fujiwara H, Yoshida H, Satoh T, Yonemori K, Nagao S, Matsumoto T, Kobayashi H, Bourgeois H, Harter P, Mosconi AM, Vazquez IP, Reinthaller A, Fujita T, Rowe P, Pujade-Lauraine E, Ray-Coquard I
J Gynecol Oncol, 32(5):e82, 01 Sep 2021
Cited by: 6 articles | PMID: 34378365 | PMCID: PMC8362816
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.
Zelek L, Debourdeau P, Bourgeois H, Wagner JP, Brocard F, Lefeuvre-Plesse C, Chauffert B, Leheurteur M, Bachet JB, Simon H, Mayeur D, Scotté F
Oncologist, 26(10):e1870-e1879, 22 Jul 2021
Cited by: 5 articles | PMID: 34216177 | PMCID: PMC8488783
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T, PERUSE investigators
Ann Oncol, 32(10):1245-1255, 02 Jul 2021
Cited by: 26 articles | PMID: 34224826
Add to export list
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Lim B, Potter DA, Salkeni MA, Silverman P, Haddad TC, Forget F, Awada A, Canon JL, Danso M, Lortholary A, Bourgeois H, Tan-Chiu E, Vincent S, Bahamon B, Galinsky KJ, Patel C, Neuwirth R, Leonard EJ, Diamond JR
Clin Cancer Res, 27(12):3329-3338, 05 Apr 2021
Cited by: 8 articles | PMID: 33820779
Add to export list
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
Gelmon KA, Fasching PA, Couch FJ, Balmaña J, Delaloge S, Labidi-Galy I, Bennett J, McCutcheon S, Walker G, O'Shaughnessy J, Collaborating Investigators
Eur J Cancer, 152:68-77, 01 Jun 2021
Cited by: 13 articles | PMID: 34087573
Add to export list
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
Cabel L, Berger F, Cottu P, Loirat D, Rampanou A, Brain E, Cyrille S, Bourgeois H, Kiavue N, Deluche E, Ladoire S, Campone M, Pierga JY, Bidard FC
Br J Cancer, 124(7):1207-1213, 21 Jan 2021
Cited by: 26 articles | PMID: 33473163 | PMCID: PMC8007590
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 134 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding